Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-055976
Filing Date
2024-06-26
Accepted
2024-06-26 10:13:46
Documents
82
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0207811-10q_chinaheal.htm   iXBRL 10-Q 791836
2 CERTIFICATION ea020781101ex31-1_china.htm EX-31.1 12188
3 CERTIFICATION ea020781101ex31-2_china.htm EX-31.2 12345
4 CERTIFICATION ea020781101ex32-1_china.htm EX-32.1 5182
5 GRAPHIC image_001.jpg GRAPHIC 40468
  Complete submission text file 0001213900-24-055976.txt   5010685

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE chhe-20240331.xsd EX-101.SCH 58535
7 XBRL CALCULATION FILE chhe-20240331_cal.xml EX-101.CAL 36788
8 XBRL DEFINITION FILE chhe-20240331_def.xml EX-101.DEF 230496
9 XBRL LABEL FILE chhe-20240331_lab.xml EX-101.LAB 431819
10 XBRL PRESENTATION FILE chhe-20240331_pre.xml EX-101.PRE 240046
86 EXTRACTED XBRL INSTANCE DOCUMENT ea0207811-10q_chinaheal_htm.xml XML 594909
Mailing Address 3199-1 LONGXIANG ROAD, SONGBEI DISTRICT HARBIN CITY HEILONGJIANG PROVINCE F4 150028
Business Address 3199-1 LONGXIANG ROAD, SONGBEI DISTRICT HARBIN CITY HEILONGJIANG PROVINCE F4 150028 011-86-451-51719407
China Health Industries Holdings, Inc. (Filer) CIK: 0001309057 (see all company filings)

EIN.: 860827216 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-51060 | Film No.: 241071031
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)